Cannabis Report
Lithium
Home > Boards > US OTC > Cannabis >

Nemus Bioscience, Inc. (NMUS)

NMUS RSS Feed
Add NMUS Price Alert      Hide Sticky   Hide Intro
Moderator: zenvesting, Southern Gal, MERCURIAL, MADDSTACKER
Search This Board: 
Last Post: 8/17/2018 7:25:13 AM - Followers: 135 - Board type: Free - Posts Today: 0


 

 NEMUS BIOSCIENCE™ provides pharmaceutical research and development services focused on discovering, developing, and commercializing new chemical entities from a class of chemically diverse compounds. We develop novel and proprietary classes of product candidates that are designed to improve therapeutic options through enhanced chemical engineering that allow drug candidates to have more predictable bioavailability and pharmacokinetics leading to optimized efficacy and safety.

NEMUS Bioscience Inc., a Nevada corporation, is a SEC fully reporting company listed on the  under the symbol NMUS.

Company Website:  http://www.nemusbioscience.com/home.html

Filings and disclosure with Level 2 quotes:  http://www.otcmarkets.com/stock/NMUS/quote

Contact:

(949) 396-0330
E-MAIL: BRIAN@NEMUSBIO.COM
600 ANTON BLVD, SUITE 1100, COSTA MESA, CA 92626


 

Nemus Bioscience (NMUS) Presentation (47 minutes):  
https://www.youtube.com/watch?v=tYV2PEaj6os

Presentation at the 18th Annual Rodman & Renshaw Global Investment Conference in New York City September 12th, 2016: 
http://s2.q4cdn.com/753474459/files/doc_presentations/2016/Rodman-Conf-September-2016_FINAL.pdf



 


Major press releases:

A Sit Down With Nemus Bioscience; Cannabinoids In Focus Feb. 1, 2017 11:06 AM ET Nemus Bioscience, Inc. (NMUS)  
 

Nemus Bioscience Announces Milestones in the Development of Fully Synthetic Clinical-Grade Active Pharmaceutical Ingredient (API) for Drug Candidates NB1111 and NB2111 and Formulation Contract with AMRI and Catalent Pharma Solutions -


Cannabinoid Drug Advancements Take Off After Quantum Shift in U.S. Drug Policy


Nemus Bioscience Announces Presentation of NB1111 Impact on Intraocular Pressure (IOP) in Normotensive Ocular Model at the National Meeting of the American Association of Pharmaceutical Scientists (AAPS)

 

Nemus Bioscience Announces Enhanced Ocular Tissue Concentration by the Proprietary Prodrug of Tetrahydrocannabinol (NB1111) - Associated With a Superior Decline in Intra-Ocular Pressure (IOP) in an Animal Model

 

Nemus Bioscience, Inc. Announces Letter of Intent to License Biosynthetic Technology to Manufacture Its Proprietary Cannabinoid Molecules From Teewinot Life Sciences Corp.


NEMUS Bioscience Identifies Unique Cannabidiol (CBD) Derivative as a Lead Candidate in Its Neuropathy-Related Pain Management Program 


CANNAINVESTOR Magazine Top 20 Cannabis Stocks 

 

NEMUS Bioscience CEO to Present at the 28th Annual ROTH Conference 

 

NEMUS Bioscience, Inc. Signs Agreement With Albany Molecular Research Inc. (AMRI) to Manufacture Cannabinoid-Based Active Pharmaceutical Ingredients 

 

NEMUS Bioscience Prodrug of THC (NB1111) Completes Validation Stage of Glaucoma Testing and Development 

 

Nemus Enters Into Research Agreement With the University of Mississippi to Develop Cannabinoid-Based Therapies for Chemotherapy-Induced Peripheral Neuropathy (CIPN) 

 

NMUS Security Details

Share Structure - as of Feb 1, 2017
Source: otcmarkets.com

Authorized Shares: 236,000,000
Outstanding Shares: 132,414,079 a/o April 18, 2018

      - Restricted  90,689,442
    - Unrestricted  41,724,637

           - Float  14,218,313 a/o April 18, 2018 
   Par Value 0.001


Transfer Agent: Clear Trust, LLC

Cannabis Report
Lithium
NMUS
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NMUS News: Amended Quarterly Report (10-q/a) 08/17/2018 06:05:38 AM
NMUS News: Quarterly Report (10-q) 08/10/2018 05:54:30 PM
NMUS News: Current Report Filing (8-k) 08/01/2018 08:39:51 AM
NMUS News: Statement of Changes in Beneficial Ownership (4) 07/23/2018 05:19:26 PM
NMUS News: Securities Registration: Employee Benefit Plan (s-8) 07/20/2018 02:25:06 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#5116  Sticky Note Nemus Investor Presentation 6/4/18 MERCURIAL 07/28/18 01:33:05 PM
#4862  Sticky Note I was afforded the opportunity to speak with TheMonolith 04/19/18 11:35:50 PM
#3633  Sticky Note NMUS DD TheMonolith 01/21/18 10:38:25 AM
#5175   Why would longs buy 19 when we're waiting greenwillow 08/17/18 07:25:13 AM
#5173   ETRF 0.19 477,435 500k on the ask in the teens... AntonChigurh 08/17/18 03:17:41 AM
#5172   heading to under a dime? Southern Gal 08/16/18 03:21:44 PM
#5171   Nmus & emerald gotta get their asses in gear.... greenwillow 08/14/18 09:12:40 AM
#5170   When is the road show gunna start! shakeshack 08/13/18 10:11:13 PM
#5169   Did some looking around, shakeshack 08/13/18 01:46:23 PM
#5168   200,000+ on ask at .2 should keep this Investor Jesus 08/13/18 11:12:15 AM
#5166   "On February 28, 2018, in conjunction with the AntonChigurh 08/10/18 11:03:13 PM
#5165   i think you will get plenty of chances to AntonChigurh 08/07/18 10:34:57 PM
#5164   Yes, bring us some dimes. greenwillow 08/07/18 12:20:39 PM
#5163   emerald got their shares for a dime AntonChigurh 08/07/18 12:16:40 PM
#5162   Not looking so good here, how low will Vapobag 08/07/18 11:07:48 AM
#5161   Not if you're loading the boat. greenwillow 08/06/18 05:04:53 PM
#5160   close at .1 something AntonChigurh 08/06/18 04:50:49 PM
#5159   Emerald owns over 60% of this company thats shakeshack 08/04/18 05:32:02 PM
#5158   Emeralds little gem , pick up your feet $NMUS$ bigmoneyyyyyyyyy 08/03/18 10:25:40 AM
#5157   The difference between 2016 press release and now mmjbuyer 08/02/18 10:14:50 PM
#5156   The company has never submitted an IND to zenvesting 08/02/18 09:54:59 PM
#5155   There is a lot strange with this company AntonChigurh 08/02/18 08:55:49 PM
#5154   long awaited news special price action for loyal Mandofellow 08/02/18 11:58:23 AM
#5153   Only difference Iv'e found this time round is Investor Jesus 08/02/18 11:43:59 AM
#5152   Every time it starts to look bullish, it jjr04001 08/02/18 10:40:26 AM
#5151   Yeah, it sure is strange. Maybe they're an Investor Jesus 08/02/18 08:51:30 AM
#5150   From their presentation in june 2018 shakeshack 08/02/18 01:05:44 AM
#5149   Look at the company current address AntonChigurh 08/02/18 12:44:26 AM
#5148   Still here. Hang on to this gentlemen. They Vinpat 08/01/18 10:52:07 PM
#5147   Performing the study in Australia make a difference? shakeshack 08/01/18 09:27:05 PM
#5146   Admittedly, the granting of Epidiolex was good news Investor Jesus 08/01/18 08:57:09 PM
#5145   FDA never gave these sorts of therapies a greenwillow 08/01/18 08:42:23 PM
#5144   Please share what is different this time round. Investor Jesus 08/01/18 08:39:39 PM
#5143   Finally, a couple items from the 8-K filed today: Investor Jesus 08/01/18 08:37:49 PM
#5142   Why should we expect a different response? greenwillow 08/01/18 08:34:40 PM
#5141   Anton is back! Where's Vinpat? Investor Jesus 08/01/18 08:23:40 PM
#5140   The point is you just suggested that there Investor Jesus 08/01/18 07:51:59 PM
#5139   And if shares were sold, shares were bought. BrophInvest 08/01/18 07:46:07 PM
#5138   if shares were bought, shares were sold Southern Gal 08/01/18 07:37:08 PM
#5137   http://www.nemusbioscience.com/investor-relations/investor-news/investor-news-de AntonChigurh 08/01/18 03:24:11 PM
#5136   Seems to be more buying than selling. Things BrophInvest 08/01/18 11:59:05 AM
#5135   No clue here. greenwillow 08/01/18 10:56:01 AM
#5134   News was fully anticipated so I wonder if TheMonolith 08/01/18 10:00:56 AM
#5133   Wow, interesting open. greenwillow 08/01/18 09:36:31 AM
#5132   Me to ...:( MADDSTACKER 08/01/18 09:25:33 AM
#5131   Thanks Greenwillow! This global contract research and manufacturing zoom22 08/01/18 09:18:08 AM
#5130   https://www.amriglobal.com/ greenwillow 08/01/18 09:09:44 AM
#5129   I sure do miss it :-) TheMonolith 08/01/18 09:03:30 AM
#5128   Tweed breaking resistance lets get this bull market MADDSTACKER 08/01/18 09:01:59 AM
#5127   Anticipated, but good to see it executed. Hopefully TheMonolith 08/01/18 09:01:05 AM
#5126   Nemus Bioscience, Inc. Signs Agreement with Albany Molecular Southern Gal 08/01/18 09:00:55 AM
#5125   Yes! It is. Go $NMUS MERCURIAL 08/01/18 08:46:40 AM
#5124   Let’s goooo MADDSTACKER 08/01/18 08:39:41 AM
PostSubject